- Very low LDL cholesterol in acute coronary syndrome2020 | Second Faculty of Medicine
- Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial2017 | First Faculty of Medicine
- How deep is LDL cholesterol fall?2014 | First Faculty of Medicine
- Some of the myths of contemporary lipidology2015 | First Faculty of Medicine
- Why not to interfere with LDL-cholesterol freefall and why not to talk badly about statins2018 | Second Faculty of Medicine